Search research articles
Contact Us
Filters
Showing results (461-470 of 612) with videos related to
Page
of 62
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 20, 2011
Clinical and biologic features predictive of survival after relapse of neuroblastoma: a report from the International Neuroblastoma Risk Group project
Wendy B London, Victoria Castel, Tom Monclair, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 21, 2017
Cabozantinib in hepatocellular carcinoma: results of a phase 2 placebo-controlled randomized discontinuation study
R K Kelley, C Verslype, A L Cohn, et al.
The New England Journal of Medicine
|
February 25, 1988
Transmission of human immunodeficiency virus (HIV) by blood transfusions screened as negative for HIV antibody
J W Ward, S D Holmberg, J R Allen, et al.
The New England Journal of Medicine
|
September 16, 1993
Two controlled trials of rifabutin prophylaxis against Mycobacterium avium complex infection in AIDS
S D Nightingale, D W Cameron, F M Gordin, et al.
EJC Paediatric Oncology
|
January 12, 2024
Persistence of Racial and Ethnic Disparities in Risk and Survival for Patients with Neuroblastoma over Two Decades
Mohansrinivas Chennakesavalu, Caileigh Pudela, Mark A Applebaum, et al.
Molecular Cancer Therapeutics
|
January 25, 2019
Maternal Embryonic Leucine Zipper Kinase (MELK), a Potential Therapeutic Target for Neuroblastoma
Alexandre Chlenski, Chanyoung Park, Marija Dobratic, et al.
JAMA
|
April 1, 1992
Spectrum of disease in persons with human immunodeficiency virus infection in the United States
K M Farizo, J W Buehler, M E Chamberland, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 4, 2009
Hematologic response to three alternative dosing schedules of azacitidine in patients with myelodysplastic syndromes
Roger M Lyons, Thomas M Cosgriff, Sanjiv S Modi, et al.
ACS Omega
|
September 23, 2016
Converting Light Energy to Chemical Energy: A New Catalytic Approach for Sustainable Environmental Remediation
Michelle A Nguyen, Elsayed M Zahran, Azaan S Wilbon, et al.
Molecular Cancer Therapeutics
|
April 14, 2005
Expression of multidrug transporter MRP4/ABCC4 is a marker of poor prognosis in neuroblastoma and confers resistance to irinotecan in vitro
Murray D Norris, Janice Smith, Kara Tanabe, et al.
Page
of 62
Search research articles
Search
Showing results (461-470 of 612) with videos related to
Sort By:
Page
of 62
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 20, 2011
Clinical and biologic features predictive of survival after relapse of neuroblastoma: a report from the International Neuroblastoma Risk Group project
Wendy B London, Victoria Castel, Tom Monclair, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 21, 2017
Cabozantinib in hepatocellular carcinoma: results of a phase 2 placebo-controlled randomized discontinuation study
R K Kelley, C Verslype, A L Cohn, et al.
The New England Journal of Medicine
|
February 25, 1988
Transmission of human immunodeficiency virus (HIV) by blood transfusions screened as negative for HIV antibody
J W Ward, S D Holmberg, J R Allen, et al.
The New England Journal of Medicine
|
September 16, 1993
Two controlled trials of rifabutin prophylaxis against Mycobacterium avium complex infection in AIDS
S D Nightingale, D W Cameron, F M Gordin, et al.
EJC Paediatric Oncology
|
January 12, 2024
Persistence of Racial and Ethnic Disparities in Risk and Survival for Patients with Neuroblastoma over Two Decades
Mohansrinivas Chennakesavalu, Caileigh Pudela, Mark A Applebaum, et al.
Molecular Cancer Therapeutics
|
January 25, 2019
Maternal Embryonic Leucine Zipper Kinase (MELK), a Potential Therapeutic Target for Neuroblastoma
Alexandre Chlenski, Chanyoung Park, Marija Dobratic, et al.
JAMA
|
April 1, 1992
Spectrum of disease in persons with human immunodeficiency virus infection in the United States
K M Farizo, J W Buehler, M E Chamberland, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 4, 2009
Hematologic response to three alternative dosing schedules of azacitidine in patients with myelodysplastic syndromes
Roger M Lyons, Thomas M Cosgriff, Sanjiv S Modi, et al.
ACS Omega
|
September 23, 2016
Converting Light Energy to Chemical Energy: A New Catalytic Approach for Sustainable Environmental Remediation
Michelle A Nguyen, Elsayed M Zahran, Azaan S Wilbon, et al.
Molecular Cancer Therapeutics
|
April 14, 2005
Expression of multidrug transporter MRP4/ABCC4 is a marker of poor prognosis in neuroblastoma and confers resistance to irinotecan in vitro
Murray D Norris, Janice Smith, Kara Tanabe, et al.
Page
of 62